Kidney Week Educational Symposia-Redefining the IgAN Paradigm: Early Detection, Targeted Immunotherapy, and Clinical Reality

Video Transcription

Video Summary

<strong style="box-sizing: border-box; font-weight: bold; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;">Moderator(s):</strong><span style="color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff; float: none; display: inline;"> Michael Choi</span><br style="box-sizing: border-box; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;" /><br style="box-sizing: border-box; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;" /><strong style="box-sizing: border-box; font-weight: bold; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;">Presentation(s):</strong><br style="box-sizing: border-box; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;" />
<ul style="box-sizing: border-box; margin-top: 0px; margin-bottom: 10px; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;">
<li style="box-sizing: border-box;"><strong style="box-sizing: border-box; font-weight: bold;">Introduction</strong> - Michael Choi</li>
<li style="box-sizing: border-box;"><strong style="box-sizing: border-box; font-weight: bold;">Targeting the Dual-Ligand Pathway: APRIL, BAFF, and the Shift Toward Predictive Biomarkers in IgAN Management</strong> - Shikha Wadhwani</li>
<li style="box-sizing: border-box;"><strong style="box-sizing: border-box; font-weight: bold;">Incorporating PROs and Holistic Strategies to Improve Quality of Life in IgAN</strong> - Natasha Freeman</li>
</ul>
<em style="box-sizing: border-box; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;">Support is provided by an educational grant from Vera Therapeutics, Inc.</em>&nbsp;

Asset Subtitle

Moderator(s): Michael Choi

Presentation(s):

Introduction - Michael Choi
Targeting the Dual-Ligand Pathway: APRIL, BAFF, and the Shift Toward Predictive Biomarkers in IgAN Management - Shikha Wadhwani
Incorporating PROs and Holistic Strategies to Improve Quality of Life in IgAN - Natasha Freeman

Support is provided by an educational grant from Vera Therapeutics, Inc.

Meta Tag

Pathway(s) Glomerular Diseases

Pathway(s) Pathology

Session Type ES - Educational Symposium

Speaker(s) Michael Choi

Speaker(s) Shikha Wadhwani

Speaker(s) Natasha Freeman

Keywords

IgA nephropathy

IgAN

APRIL

BAFF

B-cell maturation

galactose-deficient IgA

targeted immunotherapy

phase 3 trial

proteinuria

biomarkers

patient-reported outcomes

dual-ligand pathway

predictive biomarkers

disease management

quality of life

holistic strategies

Vera Therapeutics

Michael Choi